| 000 | 01517 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513004030.0 | ||
| 264 | 0 | _c19811118 | |
| 008 | 198111s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/clpt.1981.177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTobert, J A | |
| 245 | 0 | 0 |
_aEffect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cSep 1981 |
||
| 300 |
_a385-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAluminum Hydroxide _xmetabolism |
| 650 | 0 | 4 |
_aAntacids _xpharmacology |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiflunisal _xblood |
| 650 | 0 | 4 | _aFasting |
| 650 | 0 | 4 | _aFood |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnesium Hydroxide _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSalicylates _xmetabolism |
| 650 | 0 | 4 | _aSuspensions |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDeSchepper, P | |
| 700 | 1 | _aTjandramaga, T B | |
| 700 | 1 | _aMullie, A | |
| 700 | 1 | _aBuntinx, A P | |
| 700 | 1 | _aMeisinger, M A | |
| 700 | 1 | _aHuber, P B | |
| 700 | 1 | _aHall, T L | |
| 700 | 1 | _aYeh, K C | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 30 _gno. 3 _gp. 385-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.1981.177 _zAvailable from publisher's website |
| 999 |
_c7023447 _d7023447 |
||